-
Philip Barter, Professor and Director of the Heart Research Institute at the
University of Sydney in Australia, discusses why the upcoming METEOR trial results
will be of interest, and cites a few of his personal highlights of the meeting.
Listen to the audio report
-
Professor Christie Ballantyne of Baylor College of Medicine, Houston, TX, USA,
gives his reaction to the METEOR trial results, which compared statin therapy and
placebo in preventing atherosclerosis in the carotid artery.
Listen to the audio report
-
Dr. Marvin Konstam, Chief of Cardiology at New England Medical Center and Professor
of Medicine at Tufts University School, Boston, MA, USA, describes the reasoning behind
the EVEREST trial and the results presented at ACC.07.
Listen to the audio report
-
“Women develop their coronary disease a decade later than men, so we’re looking at
lifetime risk,” says Dr. Nanette Wenger (Emory University School of Medicine and
Grady Memorial Hospital in Atlanta, GA, USA).
Listen to the audio report
-
Professor William E. Boden from Buffalo General Hospital in New York, USA talks
to InCirculation.net about the results of the COURAGE trial. “We were all surprised
at how good medical therapy was for angina relief,” he said.
Listen to the audio report
-
Professor Richard Conti (University of Florida College of Medicine, Gainesville,
FL, USA) discusses the MERLIN and COURAGE trials. “I think even Dr. Boden ... was
surprised about how well the medical therapy patients did,” he says.
Listen to the audio report
-
Professor Steven Markowitz (Weill Cornell Medical College, New York, NY, USA),
shares his personal highlights of the meeting, including implications of the ALPHA
trial, and the excitement around the effect of resynchronization in cardiac arrhythmias.
Listen to the audio report